Other
Debt issued (Note 13)
Medtronic Debt issued (Note 13) decreased by 100.0% to $0.00 in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $3.21B to $0.00.
Analysis
StatementIncome Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026Aug 26, 2025
How to read this metric
High proceeds indicate active debt financing to support growth or liquidity, while low proceeds may suggest reliance on internal cash or limited market access.
Detailed definition
Cash inflows received from the issuance of long-term debt instruments, such as bonds or bank loans. This metric reflects...
Peer comparison
Standard financing activity metric across all capital-intensive industries.
Metric ID:
other_proceeds_from_issuance_of_long_term_debtHistorical Data
12 periods
| Q4 '21 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | -$3.43B | $0.00 | $3.43B | $1.98B | $0.00 | $3.21B | -$3.21B | $0.00 | $3.21B | $1.46B | $0.00 |
| QoQ Change | — | — | +100.0% | — | -42.3% | -100.0% | — | -200.0% | +100.0% | — | -54.4% | -100.0% |
| YoY Change | — | — | — | +200.0% | — | — | — | -193.6% | -100.0% | — | +145.6% | -100.0% |
Range-$3.43B – $3.43B
Avg YoY Growth-9.6%
Median YoY Growth-100.0%
Current Streak2+ quarters decline
Debt issued (Note 13) at Other Companies
Frequently Asked Questions
- What is Medtronic's debt issued (note 13)?
- Medtronic (MDT) reported debt issued (note 13) of $0.00 in Q2 2025.
- How has Medtronic's debt issued (note 13) changed year-over-year?
- Medtronic's debt issued (note 13) decreased by 100.0% year-over-year, from $3.21B to $0.00.
- What does debt issued (note 13) mean?
- Cash raised through the issuance of long-term debt.